(Q24248787)

29 July 2017

1 reference

title

Antiplatelet therapy for acute ischaemic stroke (English)

1 reference

29 July 2017

P Sandercock

1

0 references

G Gubitz

2

0 references

P Foley

3

0 references

C Counsell

4

0 references

G Gubitz

1

1 reference

29 July 2017

P Sandercock

2

1 reference

29 July 2017

C Counsell

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

22 April 2003

0 references

2003

0 references

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

1 reference

29 July 2017

CD000029

1 reference

29 July 2017

2

1 reference

Effects of ticlopidine on the neurologic outcome and the hemorheologic pattern in the postacute phase of ischemic stroke: a pilot study.

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Complications after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Aspirin as an antiplatelet drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Evidence for episodic platelet activation in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Platelet activation and lipid peroxidation in patients with acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

7 January 2021

Effect of therapy on platelet activating factor-induced aggregation in acute stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

7 January 2021

Interobserver agreement for the assessment of handicap in stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

7 January 2021

Fatal hemorrhagic transformation of acute cerebral infarction after the use of abciximab

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

7 January 2021

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

7 January 2021

Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

7 January 2021

Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029

7 January 2021

10.1002/14651858.CD000029

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference